1. Home
  2. DNLI vs GEL Comparison

DNLI vs GEL Comparison

Compare DNLI & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • GEL
  • Stock Information
  • Founded
  • DNLI 2013
  • GEL 1996
  • Country
  • DNLI United States
  • GEL United States
  • Employees
  • DNLI N/A
  • GEL N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • GEL Oil Refining/Marketing
  • Sector
  • DNLI Health Care
  • GEL Energy
  • Exchange
  • DNLI Nasdaq
  • GEL Nasdaq
  • Market Cap
  • DNLI 2.2B
  • GEL 1.8B
  • IPO Year
  • DNLI 2017
  • GEL 1996
  • Fundamental
  • Price
  • DNLI $14.85
  • GEL $15.96
  • Analyst Decision
  • DNLI Strong Buy
  • GEL Buy
  • Analyst Count
  • DNLI 13
  • GEL 3
  • Target Price
  • DNLI $32.64
  • GEL $19.50
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • GEL 231.6K
  • Earning Date
  • DNLI 11-03-2025
  • GEL 10-30-2025
  • Dividend Yield
  • DNLI N/A
  • GEL 4.11%
  • EPS Growth
  • DNLI N/A
  • GEL N/A
  • EPS
  • DNLI N/A
  • GEL N/A
  • Revenue
  • DNLI N/A
  • GEL $2,893,959,000.00
  • Revenue This Year
  • DNLI N/A
  • GEL N/A
  • Revenue Next Year
  • DNLI $94,232.03
  • GEL $19.09
  • P/E Ratio
  • DNLI N/A
  • GEL N/A
  • Revenue Growth
  • DNLI N/A
  • GEL 42.14
  • 52 Week Low
  • DNLI $10.57
  • GEL $9.86
  • 52 Week High
  • DNLI $33.33
  • GEL $17.77
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.38
  • GEL 50.64
  • Support Level
  • DNLI $15.53
  • GEL $15.51
  • Resistance Level
  • DNLI $17.02
  • GEL $16.45
  • Average True Range (ATR)
  • DNLI 0.75
  • GEL 0.50
  • MACD
  • DNLI -0.23
  • GEL 0.07
  • Stochastic Oscillator
  • DNLI 9.18
  • GEL 67.00

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: